BOA1

Featured post

#Avian #Influenza #H7N9 in #China: Preventing the Next #SARS (@WHO, Apr. 2 ‘17)

  Title : #Avian #Influenza #H7N9 in #China: Preventing the Next #SARS. Subject : Avian Influenza, H7N9 subtype (Asian Lineage), poultry e...

18 Apr 2017

#Influenza and other #Respiratory #Viruses #Research #References #Library–April 18 2017 Issue

 

Title: #Influenza and other #Respiratory #Viruses #Research #References #Library–April 18 2017 Issue.

Subject: Human and Animal Influenza Viruses, other respiratory pathogens research, weekly references library update.

Source: AMEDEO, homepage: (LINK).

Code: [  R  ]

_____

This Week’s References:

___

  1. WANG Y, Wu J, Xue C, Wu Z, et al.
    • A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
  2. GRONSANG D, Bui AN, Trinh DQ, Bui VN, et al.
    • Characterization of cross-clade monoclonal antibodies against H5N1 highly pathogenic avian influenza virus and their application to the antigenic analysis of diverse H5 subtype viruses.
  3. DEEG CM, Hassan E, Mutz P, Rheinemann L, et al.
    • In vivo evasion of MxA by avian influenza viruses requires human signature in the viral nucleoprotein.
  4. LI Y, Qi W, Qiao J, Chen C, et al.
    • Evolving HA and PB2 genes of influenza A (H7N9) viruses in the fifth wave - Increasing threat to both birds and humans?
  5. ZHANG F, Bi Y, Wang J, Wong G, et al.
  6. HUANG X, Mengersen K, Milinovich G, Hu W, et al.
    • Effect of weather variability on seasonal influenza among different age groups in Queensland, Australia: A Bayesian spatiotemporal analysis.
  7. TZARUM N, McBride R, Nycholat CM, Paulson JC, et al.
  8. SHIN D, Lee J, Park JH, Min JY, et al.
    • Double PHD Fingers 2 (DPF2) Promotes the Immune Escape of Influenza Virus by Suppressing Interferon-beta Production.
  9. DU Y, Chen M, Yang J, Jia Y, et al.
    • Molecular Evolution and Emergence of H5N6 Avian Influenza Virus in Central China.
  10. FLORIN TA, Plint AC, Zorc JJ.
  11. MCLEAN HQ, Caspard H, Griffin MR, Poehling KA, et al.
    • Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
  12. RAY GT, Lewis N, Goddard K, Ross P, et al.
    • Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines.
  13. HOFSTETTER AM, Robinson JD, Lepere K, Cunningham M, et al.
    • Clinician-parent discussions about influenza vaccination of children and their association with vaccine acceptance.
  14. AIREY J, Albano FR, Sawlwin DC, Jones AG, et al.
    • Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study.
  15. HENDIN HE, Pillet S, Lara AN, Wu CY, et al.
    • Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.
  16. CHUTIWITOONCHAI N, Mano T, Kakisaka M, Sato H, et al.
    • Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development.
  17. IZZARD L, Dlugolenski D, Xia Y, McMahon M, et al.

-

Keywords: Research; Abstracts; Influenza References Library.

------